Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Moula

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Hippokratia|July 18, 2014
Primary rectal malignant melanoma-case reportP Gavriilidis, E Moula, A Nikolaidou
Human Gene Therapy|December 8, 2023
Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67<sup>phox</sup>-Deficient Chronic Granulomatous DiseaseThomas E Whittaker, Shefta E Moula, Sameer Bahal, et al.
Cell Reports. Medicine|May 14, 2026
Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia modelsJeffrey Pido-Lopez, Shefta E Moula, Enas Shaban, et al.
The Journal of Allergy and Clinical Immunology|March 13, 2024
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemiaSameer Bahal, Marta Zinicola, Shefta E Moula, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequencesArun Sankaradoss, Suraj Jagtap, Junaid Nazir, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Hippokratia|July 18, 2014
Primary rectal malignant melanoma-case reportP Gavriilidis, E Moula, A Nikolaidou
Human Gene Therapy|December 8, 2023
Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67<sup>phox</sup>-Deficient Chronic Granulomatous DiseaseThomas E Whittaker, Shefta E Moula, Sameer Bahal, et al.
Cell Reports. Medicine|May 14, 2026
Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia modelsJeffrey Pido-Lopez, Shefta E Moula, Enas Shaban, et al.
The Journal of Allergy and Clinical Immunology|March 13, 2024
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemiaSameer Bahal, Marta Zinicola, Shefta E Moula, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequencesArun Sankaradoss, Suraj Jagtap, Junaid Nazir, et al.
Pageof 1